Le Lézard
Classified in: Health
Subject: SVY

The global medication management system market is expected to reach USD 5.97 billion by 2025 at a CAGR of 20.5%


LONDON, Jan. 22, 2018 /PRNewswire/ -- Medication Management System Market Analysis By Software, By Mode of Delivery (On-premise, Web-based, Cloud-based), By End Use, By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2014 - 2025

Download the full report: https://www.reportbuyer.com/product/5291699

The global medication management system market is expected to reach USD 5.97 billion by 2025 at a CAGR of 20.5%

Rise in number of prescriptions globally, increase in investments by hospitals for workflow management, advanced technologies, and rise in government reforms and policies boosting integration of IT in healthcare are estimated to drive market growth.

Rise in challenges faced by healthcare professionals for efficient management of clinical operations, streamlined workflow, and reduced healthcare costs drive the demand for automated solutions in healthcare facilities. Rapid growth in prescriptions has increased the burden on care providers to efficiently manage prescriptions of patients and minimize medication errors.

Thus, increase in number of prescriptions is one crucial factor driving market growth. In addition, shortage of pharmacists and healthcare professionals will further boost the adoption of IT solutions in healthcare facilities.

There is a rise in investments by hospitals to streamline clinical processes and they have been purchasing new software to manage workflow, which is expected to boost market growth. For instance, in March 2017, Saudi German Hospital-Dubai automated its medication management workflow by integrating Omnicell's solutions.

Reforms, policies, and initiatives are being taken by governments to increase the adoption of healthcare IT across the globe, which is expected to drive market growth. For instance, the German National Medication Plan is an initiative directed toward enhancing medication management software in hospitals and pharmacies in Germany.

Further key findings from the report suggest:
? Inventory management solutions held a majority share in the market in 2016 due to rising need to reduce issues such as stockout and overstock
? Hospitals held the largest share by end use owing to rise in investments by hospitals to upgrade their IT infrastructure
? Cloud-based solutions dominated the market by mode of delivery owing to greater data security
? North America dominated the global market owing to high adoption of healthcare IT and technological advancements
? Key players in this market are Allscripts, Becton, Dickinson and Company (CareFusion), GE Healthcare, McKesson Corporation, Cerner Corporation, and Omnicell, Inc.

Download the full report: https://www.reportbuyer.com/product/5291699

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 23:33
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

at 22:54
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 22:03
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIOŽ (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...



News published on and distributed by: